We have released 11th Mar’18 – Dec’17 earnings update on Acrysil, Wim Plast and CARE Rating. The same has been produced below. For other updates, please log into the website at the following link – https://katalystwealth.com/index.php/my-account/
Date: 11th Mar’18
Acrysil (BSE – 524091) – Sep’11 Alpha stock
CMP – 522.90 (BSE)
Rating – Positive – 3% weightage; this is not an investment advice (refer rating interpretation)
Acrysil 3 Years price chart Source: BSE India
For Dec’17 quarter, on consolidated basis the company has reported 17.45% growth in sales on YOY basis to Rs 48.24 crore. The growth in sales is good; however it’s on the back of base effect with Dec’16 sales being lower on account of demonetization.
As per the company’s presentation, for the nine months the domestic market has contributed 33% to sales while the exports have accounted for the remaining. It’s important to note here that around 5 years back the contribution from domestic sales was only 5%. Further, sales of appliances are growing at a relatively higher pace in comparison to SS Sinks and Quartz Sinks.
On the front of raw materials, the company has recorded gross margins of 55.97% against 60.20% in Dec’16 quarter. As per the management, MMA (Methly Methacrylate), a key raw material used in the making of quartz sinks, its prices shot up by around 20% and as a result gross margins are down by around 400 basis points.
The operating expenses have increased by only around 10%; however on account of more than 400 bps contraction in gross margins, the EBITDA is up by only 6.4% to Rs 5.86 crore with EBITDA margins of 12.14%.
We checked with the management as to why the margins come off considerably in H2 against H1 and as per them H2 has higher contribution from domestic sales (very low exports during the months of December and January) and domestically company is in investment phase and incurring decent sums on brand building and distribution expansion. In fact, domestically, company’s dealer network has expanded from 400 to 1300 in 4 years.
Interest cost is up marginally while the depreciation cost is up by 28%. Unlike last year when the company was incurring currency losses on its USD borrowings due to depreciation of UK Pound against USD, this quarter it has recorded gain of around 0.1 crore against loss of 1.00 crore in Dec’16 quarter.
As a result of the above currency impact, the PBT of the company is up by 39.3% on YOY basis to Rs 2.69 crore.
During our con-call, we checked with the management on the thought process behind launching commercial kitchen equipments and as per the management it’s a very huge space and mostly unorganized. They believe that with their fabrication capabilities and service network, they can capitalize on the market; however initially they are testing the market with outsourced products.
The stock is currently quoting around 24 times trailing twelve months earnings. We have upgraded our rating to positive, because after a consolidation of 3 years, we believe the company is now poised for decent growth on the back of both expansion in product line and expansion in reach domestically and internationally. The key risks to our assumptions will be unfavourable currency exchange and higher crude prices.
Wim Plast (BSE – 526586) – May’11 Alpha stock
CMP – 1200.00 (BSE)
Rating – Neutral; this is not an investment advice (refer rating interpretation)
Wim Plast 3 Years price chart Source: BSE India
For Dec’17 quarter, the company has reported 13.21% growth in sales on YOY basis to Rs 88.67 crore. Since some time now the company’s sales have been stagnating and this is despite having launched several new products in the last 2-3 years. We believe there’s good potential for the company to do well in air-coolers segment; however its sales will reflect in upcoming March and June quarters.
On the front of raw materials the company has recorded gross margins of 44.88% against 46.79% in Dec’16 quarter. Companies across the polymer segment have witnessed contraction in gross margins on account of around 20% increase in crude prices since the last 1 year.
Wim Plast has exercised very good control on operating expenses as the same are up only 3.48% against 13% increase in sales and as a result the EBITDA of the company is up by 14.63% on YOY basis to Rs 19.20 crore with EBITDA margins of 21.66%
Wim Plast continues to be debt free and a net interest earner, however its depreciation cost has increased and as a result the PBT of the company for the Dec’17 quarter is up by only 7.04% on YOY basis to Rs 15.32 crore.
With the dwindling impact of GST and economy showing signs of recovery, we expect the sales growth rate for the company to improve. With the recent correction in stock price, the stock is now trading around 31.5 times trailing twelve months earnings.
CARE Ratings (NSE – CARERATING) – Aug’13 Alpha stock
CMP – 1356.15 (BSE); 1349.00 (NSE)
Rating – Positive – 3% weightage; this is not an investment advice (refer rating interpretation)
CARE Rating 3 Years price chart Source: BSE India
Credit rating revenue growth can be more realistically judged on annual basis due to timing difference in recognition of surveillance revenue. Against this backdrop, the company has reported 13.44% growth in income from operations on YOY basis to Rs 74.81 crore. Prima facie, the growth in sales looks good; however as the company has changed revenue recognition policy to % completion method, the actual growth will be known only at the end of the year.
For the nine months the company has reported 12% growth in rating income.
Crisil has reported 1.5% drop in rating income in Dec’17 quarter and 2.7% growth in the last 12 months while ICRA has reported 7.27% growth in Dec’17 quarter and 7.52% growth in the last nine months.
As far as other metrics are concerned, CARE has reported an increase of 10.17% in the volume of debt rated in the last 9 months. The growth has primarily been driven by debt market while the bank loan ratings have seen a decline.
The operating expenses of the company are up by 31.31% with employee expenses being up by 40% (including ESOP charge of 3.94 crore) and as a result the EBITDA of the company is up by only 4.70% with EBITDA margins of 61.96% against 67.14% in Dec’16 quarter.
Other income is down by 30.39% YOY because of the IND-AS impact on accounting for fair value of investments. As a result, the PBT of the company is almost flat at Rs 50.22 crore.
Since few years the rating revenues have been growing in the range of 7-10%. This is also reflective of benign credit growth with banks and several infrastructure companies grappling with NPA issues. The reforms have started happening however transformation of the same into actual investment cycle pick-up may still take some time. India still lacks considerably in infrastructure and manufacturing and the reforms like demonetization, GST and factors like lower rates, good monsoon, development of bond markets, etc. should help propel the growth.
The stock is currently trading around 25 times trailing twelve months earnings (42-44 times ICRA and CRISIL respectively). Further, CRISIL bought 8.9% stake in CARE at around 1,660/- per share.
Disclosure: I have personal investment in all the 3 stocks i.e. Acrysil, Wim Plast and CARE Rating.
Ph.: +91-727-5050062, Mob: +91-9818866676
Email: [email protected]
Positive – Expected return of ~15% + on annualized basis in medium to long term for investment recommendations and in short term for Special situations
Neutral – Expected Absolute return in the range of +/- 15%
Negative – Expected Absolute return of over -15%
Coverage closure – No further update on the stock
% weightage – allocation in the subject stock with respect to equity investments
Short term – Less than 1 year
Medium term – Greater than 1 year and less than 3 years
Long term – Greater than 3 years
Research Analyst Details
Name: Ekansh Mittal Email Id: [email protected]alystwealth.com Ph: +91 727 5050062
Analyst ownership of the stock: In Acrysil, Wim Plast and CARE Rating
Details of Associates: Not Applicable
Analyst Certification: The Analyst certify (ies) that the views expressed herein accurately reflect his (their) personal view(s) about the subject security (ies) and issuer(s) and that no part of his (their) compensation was, is or will be directly or indirectly related to the specific recommendation(s) or views contained in this research report.
Disclaimer: www.katalystwealth.com (here in referred to as Katalyst Wealth) is the domain owned by Ekansh Mittal. Mr. Ekansh Mittal is the sole proprietor of Mittal Consulting and offers independent equity research services to retail clients on subscription basis. SEBI (Research Analyst) Regulations 2014, Registration No. INH100001690
Ekansh Mittal or its associates including its relatives/analyst do not hold beneficial ownership of more than 1% in the company covered by Analyst as of the last day of the month preceding the publication of the research report.
Ekansh Mittal or its associates/analyst has not received any compensation from the company/third party covered by Analyst ever.
Ekansh Mittal/Mittal Consulting/analyst has not served as an officer, director or employee of company covered by Analyst and has not been engaged in market-making activity of the company covered by Analyst.
We submit that no material disciplinary action has been taken on Ekansh Mittal by any regulatory authority impacting Equity Research Analysis.
The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision
A graph of daily closing prices of securities is available at www.bseindia.com (Choose a company from the list on the browser and select the “three years” period in the price chart
This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. Ekansh Mittal/Mittal Consulting/Katalyst Wealth is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. This document is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Ekansh Mittal or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Neither Ekansh Mittal, nor its employees, agents nor representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. Ekansh Mittal/Mittal Consulting or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement.
The recipients of this report should rely on their own investigations. Ekansh Mittal/Mittal Consulting and/or its affiliates and/or employees may have interests/ positions, financial or otherwise in the securities mentioned in this report. Mittal Consulting has incorporated adequate disclosures in this document. This should, however, not be treated as endorsement of the views expressed in the report.